{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:54:51Z","timestamp":1793652891294,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2018R1C1B6005036"],"award-info":[{"award-number":["NRF-2018R1C1B6005036"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017R1A5A2015369"],"award-info":[{"award-number":["NRF-2017R1A5A2015369"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77719-6","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T02:45:09Z","timestamp":1731293109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elevated serum growth differentiation factor 15 and decorin predict the fibrotic progression of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Jae Seung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhii-Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"5","key":"77719_CR1","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51(5), 1820\u20131832 (2010).","journal-title":"Hepatology"},{"issue":"8","key":"77719_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong, V. W., Adams, L. A., de Ledinghen, V., Wong, G. L. & Sookoian, S. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 15(8), 461\u2013478 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl","key":"77719_CR3","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.3350\/cmh.2022.0348","volume":"29","author":"T Reinson","year":"2023","unstructured":"Reinson, T., Buchanan, R. M. & Byrne, C. D. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future. Clin. Mol. Hepatol. 29(Suppl), S157\u2013S170 (2023).","journal-title":"Clin. Mol. Hepatol."},{"issue":"5","key":"77719_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5), 1836\u20131846 (2010).","journal-title":"Hepatology"},{"issue":"3","key":"77719_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13622","volume":"52","author":"A Karkucinska-Wieckowska","year":"2022","unstructured":"Karkucinska-Wieckowska, A. et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. Eur. J. Clin. Investig. 52(3), e13622 (2022).","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"77719_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.157","volume":"49","author":"LD Ly","year":"2017","unstructured":"Ly, L. D. et al. Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes. Exp. Mol. Med. 49(2), e291 (2017).","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"77719_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.331","volume":"6","author":"S Xu","year":"2015","unstructured":"Xu, S. et al. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis. 6(11), e1976 (2015).","journal-title":"Cell Death Dis."},{"issue":"8","key":"77719_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado, M. V. & Diehl, A. M. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150(8), 1769\u20131777 (2016).","journal-title":"Gastroenterology"},{"issue":"4","key":"77719_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","volume":"28","author":"NE Sunny","year":"2017","unstructured":"Sunny, N. E., Bril, F. & Cusi, K. Mitochondrial adaptation in nonalcoholic fatty liver disease: Novel mechanisms and treatment strategies. Trends Endocrinol. Metab. 28(4), 250\u2013260 (2017).","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"77719_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.3014","volume":"19","author":"KH Kim","year":"2013","unstructured":"Kim, K. H. et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat. Med. 19(1), 83\u201392 (2013).","journal-title":"Nat. Med."},{"issue":"10","key":"77719_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17(10), 1374\u20131395 (2016).","journal-title":"EMBO Rep."},{"issue":"1","key":"77719_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung, H. K. et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J. Cell Biol. 216(1), 149\u2013165 (2017).","journal-title":"J. Cell Biol."},{"issue":"3","key":"77719_CR13","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.isci.2021.102181","volume":"24","author":"SG Kang","year":"2021","unstructured":"Kang, S. G. et al. Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response. iScience 24(3), 102181 (2021).","journal-title":"iScience"},{"issue":"1","key":"77719_CR14","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1038\/s41598-018-25098-0","volume":"8","author":"KH Kim","year":"2018","unstructured":"Kim, K. H. et al. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Sci. Rep. 8(1), 6789 (2018).","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"77719_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ggi.12724","volume":"16","author":"Y Fujita","year":"2016","unstructured":"Fujita, Y., Taniguchi, Y., Shinkai, S., Tanaka, M. & Ito, M. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatr. Gerontol. Int. 16(Suppl 1), 17\u201329 (2016).","journal-title":"Geriatr. Gerontol. Int."},{"issue":"5","key":"77719_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga, S. et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann. Neurol. 78(5), 814\u2013823 (2015).","journal-title":"Ann. Neurol."},{"issue":"4","key":"77719_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/liv.13587","volume":"38","author":"BK Koo","year":"2018","unstructured":"Koo, B. K. et al. Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease. Liver Int. 38(4), 695\u2013705 (2018).","journal-title":"Liver Int."},{"issue":"10","key":"77719_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol. 17(10), 592\u2013607 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"77719_CR19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park, C. C. et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152(3), 598-607 e592 (2017).","journal-title":"Gastroenterology"},{"issue":"5","key":"77719_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao, G. et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 66(5), 1486\u20131501 (2017).","journal-title":"Hepatology"},{"issue":"9","key":"77719_CR21","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/liv.14593","volume":"40","author":"MAT Han","year":"2020","unstructured":"Han, M. A. T. et al. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. Liver Int. 40(9), 2242\u20132251 (2020).","journal-title":"Liver Int."},{"issue":"1","key":"77719_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/rej.2020.2308","volume":"24","author":"C Herpich","year":"2021","unstructured":"Herpich, C. et al. Associations between serum GDF15 concentrations, muscle mass, and strength show sex-specific differences in older hospital patients. Rejuvenation Res. 24(1), 14\u201319 (2021).","journal-title":"Rejuvenation Res."},{"key":"77719_CR23","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0054","author":"M Asrih","year":"2022","unstructured":"Asrih, M. et al. Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and\/or obesity. Endocr. Connect. https:\/\/doi.org\/10.1530\/EC-22-0054 (2022).","journal-title":"Endocr. Connect."},{"issue":"2","key":"77719_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5009\/gnl210106","volume":"16","author":"E Chang","year":"2022","unstructured":"Chang, E. et al. Multidimensional biomarker analysis including mitochondrial stress indicators for nonalcoholic fatty liver disease. Gut Liver 16(2), 171\u2013189 (2022).","journal-title":"Gut Liver"},{"issue":"4","key":"77719_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1369\/0022155412438104","volume":"60","author":"K Baghy","year":"2012","unstructured":"Baghy, K., Iozzo, R. V. & Kovalszky, I. Decorin-TGFbeta axis in hepatic fibrosis and cirrhosis. J. Histochem. Cytochem. 60(4), 262\u2013268 (2012).","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"77719_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1309\/J8CD-E9C8-X4NG-GTVG","volume":"115","author":"J Dudas","year":"2001","unstructured":"Dudas, J. et al. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am. J. Clin. Pathol. 115(5), 725\u2013735 (2001).","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"77719_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/labinvest.2010.172","volume":"91","author":"K Baghy","year":"2011","unstructured":"Baghy, K. et al. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab. Investig. 91(3), 439\u2013451 (2011).","journal-title":"Lab. Investig."},{"issue":"9","key":"77719_CR28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.5966\/sctm.2015-0323","volume":"5","author":"YO Jang","year":"2016","unstructured":"Jang, Y. O. et al. Effect of function-enhanced mesenchymal stem cells infected with decorin-expressing adenovirus on hepatic fibrosis. Stem Cells Transl. Med. 5(9), 1247\u20131256 (2016).","journal-title":"Stem Cells Transl. Med."},{"issue":"6","key":"77719_CR29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/dc12-0223","volume":"36","author":"JY Kim","year":"2013","unstructured":"Kim, J. Y. et al. Prospective study of serum adiponectin and incident metabolic syndrome: The ARIRANG study. Diabetes Care 36(6), 1547\u20131553 (2013).","journal-title":"Diabetes Care"},{"issue":"7","key":"77719_CR30","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1148\/rg.2019190034","volume":"39","author":"FF Guglielmo","year":"2019","unstructured":"Guglielmo, F. F., Venkatesh, S. K. & Mitchell, D. G. Liver MR elastography technique and image interpretation: Pearls and pitfalls. Radiographics 39(7), 1983\u20132002 (2019).","journal-title":"Radiographics"},{"issue":"6","key":"77719_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6), 1313\u20131321 (2005).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77719-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:14:17Z","timestamp":1731654857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77719-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77719-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4854781\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All aspects of this study, including research methods were conducted in strict accordance with relevant guidelines and regulations. This study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. All data were de-identified, and all study protocols and procedures were reviewed and approved by the Institutional Review Board of Wonju Severance Christian Hospital (approval No. CR317131).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Written informed consent was obtained from all participants, who have consented to the publication of any data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"27527"}}